MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech, Inc. (PMCB)

||
||

Balance Sheets Overview

Current Ratio
4029.57%
Quick Ratio
4029.57%
Cash Ratio
2307.72%
Debt to Asset Ratio
18.79%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Investment in preferred stock - ...
    • Warrant asset qcls non current
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock, at cost, 15,270,...
    • Others
Balance Sheets
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Cash and cash equivalents
17,738,991
18,603,899
20,165,535
15,406,017
Marketable equity securities
99,462
254,010
372,251
201,190
Dividends receivable
429,150
240,766
-
-
Investment in preferred stock - qcls - current
12,675,000
18,225,000
-
-
Warrant asset qcls - current
-
0
0
1,912,000
Convertible note receivable femasys - current
-
0
0
5,000,000
Prepaid expenses and other current assets
32,004
96,879
158,664
503,147
Total current assets
30,974,607
37,420,554
20,696,450
23,022,354
Intangible assets
-
0
1,549,427
1,549,427
Investment in preferred stock qcls
-
0
22,472,000
20,747,000
Warrant asset qcls non current
5,664,000
8,845,000
10,242,000
9,530,000
Warrant asset femasys
66,000
480,000
906,000
1,120,000
Other assets
7,688
7,688
7,688
7,688
Total other assets
5,737,688
9,332,688
35,177,115
32,954,115
Total assets
36,712,295
46,753,242
55,873,565
55,976,469
Accounts payable
390,535
271,102
1,200,082
1,021,339
Accrued expenses
345,656
522,831
445,656
520,656
Accrued series c dividends
32,491
32,491
32,491
35,389
Total current liabilities
768,682
826,424
1,678,229
1,577,384
Long-term portion of accrued expenses
-
0
0
0
Warrant liabilities
5,847,000
10,068,000
13,657,000
16,152,000
Derivative liabilities
281,000
878,000
1,136,000
1,693,000
Total other liabilities
6,128,000
10,946,000
14,793,000
17,845,000
Total liabilities
6,896,682
11,772,424
16,471,229
19,422,384
Convertible preferred stock-Series BPreferred Stock
-
0
0
0
Convertible preferred stock
1,890,109
1,268,892
872,323
901,996
Contingently redeemable warrants
417,000
417,000
417,000
417,000
Total temporary equity
2,307,109
1,685,892
1,289,323
1,318,996
Preferred stock value
0
0
0
0
Common stock authorized 200,000,000 shares, 0.0001 par value 26,005,715 shares issued and 10,735,649 shares outstanding as of july 31, 2026 and april 30, 2026, respectively
2,602
2,602
2,602
2,167
Additional paid-in capital
182,011,659
182,716,275
183,141,663
180,611,996
Accumulated deficit
-109,474,805
-104,393,614
-100,000,171
-100,747,031
Treasury stock, at cost, 15,270,066 shares as of july 31, 2026, and april 30, 2026, respectively
45,009,541
45,009,541
45,009,541
44,607,916
Accumulated other comprehensive loss
-21,411
-20,796
-21,540
-24,127
Total stockholders equity
27,508,504
33,294,926
38,113,013
35,235,089
Total liabilities, temporary equity and stockholders equity
36,712,295
46,753,242
55,873,565
55,976,469
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

PMCB Balance Sheet Sankey DiagramSankey diagram visualizing PMCB balance sheet for the periodCash and cashequivalents$17,738,991 (34.61%↑ Y/Y)Investment in preferredstock - qcls - current$12,675,000 Dividends receivable$429,150 Marketable equitysecurities$99,462 (-62.02%↓ Y/Y)Prepaid expenses andother current assets$32,004 (-86.56%↓ Y/Y)Warrant asset qcls noncurrent$5,664,000 (90.96%↑ Y/Y)Warrant asset femasys$66,000 (-96.42%↓ Y/Y)Other assets$7,688 (0.00%↑ Y/Y)Total current assets$30,974,607 (62.12%↑ Y/Y)Total other assets$5,737,688 (-77.94%↓ Y/Y)Total assets$36,712,295 (-18.62%↓ Y/Y)Total liabilities,temporary equity and...$36,712,295 (-18.62%↓ Y/Y)Total stockholdersequity$27,508,504 (-36.89%↓ Y/Y)Total liabilities$6,896,682 (354.07%↑ Y/Y)Total temporaryequity$2,307,109 Accumulated deficit-$109,474,805 (-17.30%↓ Y/Y)Treasury stock, at cost,15,270,066 shares as of july...$45,009,541 (0.90%↑ Y/Y)Accumulated othercomprehensive loss-$21,411 (9.83%↑ Y/Y)Additional paid-in capital$182,011,659 (0.25%↑ Y/Y)Total otherliabilities$6,128,000 (1237.99%↑ Y/Y)Total currentliabilities$768,682 (-27.54%↓ Y/Y)Convertible preferred stock$1,890,109 Contingently redeemablewarrants$417,000 Common stockauthorized 200,000,000...$2,602 (20.07%↑ Y/Y)Warrant liabilities$5,847,000 (1176.64%↑ Y/Y)Derivative liabilities$281,000 Accounts payable$390,535 (-16.05%↓ Y/Y)Accrued expenses$345,656 (-41.97%↓ Y/Y)Accrued series cdividends$32,491